
Successful Discontinuation of PD-1 Inhibitors in Metastatic Melanoma
Author(s) -
Veronica Hackethal
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000696468.40296.ad
Subject(s) - medicine , pembrolizumab , nivolumab , discontinuation , melanoma , oncology , ipilimumab , metastatic melanoma , clinical trial , immunotherapy , cancer , surgery , cancer research